First-, Second-, Third-Line Therapy for mRCC: Benchmarks for Trial Design From the IMDC
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2014.25
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2014
Authors
Publisher
Springer Science and Business Media LLC